U.S. health officials have sounded the alarm regarding counterfeit Botox injections, which have resulted in illness among 22 individuals.
According to the Centers for Disease Control and Prevention (CDC), half of the affected individuals have required hospitalization. In response to the concerning trend, the CDC issued a warning to healthcare providers on Tuesday.
The cases emerged as early as November and have been documented across 11 states. Investigations revealed that the injections were administered by unlicensed or inadequately trained individuals, or in non-medical settings such as homes or spas. Most recipients reported receiving botulinum toxin injections for cosmetic purposes.
Of particular concern, six individuals were treated for suspected botulism, a severe and potentially fatal illness caused by botulinum toxin entering the bloodstream. Symptoms of botulism include double or blurred vision, drooping eyelids, slurred speech, difficulty swallowing, and breathing issues.
Health officials emphasize the importance of seeking botulinum toxin injections exclusively from licensed professionals and promptly reporting any suspected counterfeit products. This warning underscores the critical need for vigilance and caution when seeking cosmetic procedures to ensure patient safety.
